Kepler Capital Markets set a €47.00 ($54.65) price target on Shop Apotheke Europe (ETR:SAE) in a research report released on Friday morning. The brokerage currently has a buy rating on the stock.
Several other brokerages have also recently issued reports on SAE. Commerzbank set a €42.00 ($48.84) price objective on shares of Shop Apotheke Europe and gave the company a neutral rating in a research note on Friday. Hauck & Aufhaeuser set a €51.00 ($59.30) price objective on shares of Shop Apotheke Europe and gave the company a buy rating in a research note on Thursday, February 7th.
Shares of ETR SAE opened at €39.20 ($45.58) on Friday. Shop Apotheke Europe has a 52-week low of €34.40 ($40.00) and a 52-week high of €56.00 ($65.12). The firm has a market cap of $473.34 million and a PE ratio of -17.43. The company has a debt-to-equity ratio of 2.12, a current ratio of 2.85 and a quick ratio of 1.95.
Shop Apotheke Europe Company Profile
Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Belgium, the Netherlands, France, Italy, and Spain. The company provides non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. It operates under the shop-apotheke.com brand in Germany; shop-apotheke.at brand in Austria; shop-pharmacie.fr brand in France; and farmaline brand in Belgium, Italy, and Spain.
Further Reading: Capital gains and your 401(k) or IRA
Receive News & Ratings for Shop Apotheke Europe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shop Apotheke Europe and related companies with MarketBeat.com's FREE daily email newsletter.